What type of study is this?

This is a Experimental Study study.

October 2, 2025Open Access

Supplementary figure 6 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

View Full Paper

Ask AI

Bookmark

Nrf2 hyperactivation contributes to resistance against radiotherapy in squamous cell carcinoma.
Fractionated radiation therapy affects tumor growth mediated by keap1, pointing to altered immunity.
Research utilized experimental models to investigate the interplay between radiotherapy and nrf2 signaling.
Findings indicate a need for new strategies to enhance antitumor immunity in radiotherapy.

We only have this paper's title and publication details.

Radiotherapy impacts tumor growth in head and neck squamous cell carcinoma, suggesting a role of nrf2 hyperactivation and immunity.

Keap1 tumor growth influenced by fractionated radiation therapy

No takes yet. Share an insight, caveat, or question.

Patel et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Radiotherapy impacts tumor growth in head and neck squamous cell carcinoma, suggesting a role of nrf2 hyperactivation and immunity.

Keap1 tumor growth influenced by fractionated radiation therapy